In the latest trading session, Zynerba Pharmaceuticals (ZYNE) closed at $11.87, marking a +1.63% move from the previous day. This move outpaced the S&P 500's daily gain of 0.36%. At the same time, the ...

Investors focused on the Medical space have likely heard of Zynerba Pharmaceuticals (ZYNE), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer ...

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most ...

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...

Zyne, a luxury footwear label, is now one of the many stylish brands that are part of the Duchess of Sussex's royal wardrobe. During her royal visit to Morocco, Meghan met with the brand founders, who ...

Zynerba Pharmaceuticals (ZYNE) closed at $4.18 in the latest trading session, marking a -1.88% move from the prior day. This change lagged the S&P 500's 3.25% gain on the day. At the same time, the ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...